We are analyzing https://link.springer.com/article/10.1007/s10549-005-9067-x.

Title:
From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies | Breast Cancer Research and Treatment
Description:
Numerous mouse models of mammary cancer have been developed that mimic selective aspects of human disease. The use of these models has enabled preclinical chemotherapeutic, chemoprevention, and genetic therapy studies in vivo, the testing of gene delivery systems, and the identification of tumour and metastasis suppressor and inducer genes. This review has discussed the most abundantly used murine models of mammary cancer including: spontaneous tumours, chemically induced tumours, orthotopic and syngeneic tumour transplantation, injected tumours, and genetically engineered mice with a predisposition to neoplasia. Each model has been discussed with regards to its merits and limitations for investigating the genetic and phenotypic alterations involved in the human disease as well as its potential usefulness for the development of new treatment strategies. To date no single mouse model is available with the ability to replicate the entire disease process, however, existing models continue to provide invaluable insights into breast cancer induction and progression that would be impossible to obtain using in vitro models alone.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,626,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

google, scholar, pubmed, cas, cancer, article, breast, mammary, mice, transgenic, metastasis, human, res, cell, mouse, models, bone, growth, tumor, model, biol, metastatic, oncogene, expression, tumors, metastases, development, gland, lee, tumour, cells, muller, disease, gene, int, tumorigenesis, murine, progression, factor, smith, clin, carcinoma, genetic, neoplasia, rev, nude, cardiff, research, spontaneous, induction,

Topics {✒️}

accelerates c-myc-induced tumorigenesis c-myc-induced mammary carcinogenesis month download article/chapter c-myc-induced tumorigenesis int-2 proto-oncogenes cooperate ndf/heregulin induces persistence human papillomavirus-induced carcinogenesis node-negative breast cancer extracellular signal-regulated kinase mammary-specific model demonstrates antigen transgenic mice estrogen receptor alpha-positive neu proto-oncogene involved tumor–bone cellular interactions secretory epithelial cells local tumor invasion full article pdf metastatic bone disease transgenic mouse model human breast cancer experimental metastatic properties breast cancer cells premalignant breast disease primary breast cancer nude mice int related subjects metastatic tumor growth breast cancer metastasis gene delivery systems mammary cancer including postoperative adjuvant therapy 2/neu proto-oncogene human tumor xenografts successive tumour lines tumour lines implanted transgenic mice carrying transgenic mice embo transgenic mice results breast cancer genetics keywords breast cancer single mouse model privacy choices/manage cookies artificially induced metastasis hormone-independent tumor entire disease process athymic nude mice truncated int3 gene mammary gland involution /sv40 large sandgren ep

Questions {❓}

Slamon DJ, Clark GM, Amplification of c-erbB-2 and aggressive human breast tumors?
Wagner KU, Models of breast cancer: quo vadis, animal modeling?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies
         description:Numerous mouse models of mammary cancer have been developed that mimic selective aspects of human disease. The use of these models has enabled preclinical chemotherapeutic, chemoprevention, and genetic therapy studies in vivo, the testing of gene delivery systems, and the identification of tumour and metastasis suppressor and inducer genes. This review has discussed the most abundantly used murine models of mammary cancer including: spontaneous tumours, chemically induced tumours, orthotopic and syngeneic tumour transplantation, injected tumours, and genetically engineered mice with a predisposition to neoplasia. Each model has been discussed with regards to its merits and limitations for investigating the genetic and phenotypic alterations involved in the human disease as well as its potential usefulness for the development of new treatment strategies. To date no single mouse model is available with the ability to replicate the entire disease process, however, existing models continue to provide invaluable insights into breast cancer induction and progression that would be impossible to obtain using in vitro models alone.
         datePublished:2005-12-01T00:00:00Z
         dateModified:2005-12-01T00:00:00Z
         pageStart:101
         pageEnd:113
         sameAs:https://doi.org/10.1007/s10549-005-9067-x
         keywords:
            breast cancer
             in vivo models
            metastases
            Oncology
         image:
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:96
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:P.D. Ottewell
               affiliation:
                     name: University of Sheffield
                     address:
                        name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
                        type:PostalAddress
                     type:Organization
                     name: University of Sheffield
                     address:
                        name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:R.E. Coleman
               affiliation:
                     name: University of Sheffield
                     address:
                        name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:I. Holen
               affiliation:
                     name: University of Sheffield
                     address:
                        name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies
      description:Numerous mouse models of mammary cancer have been developed that mimic selective aspects of human disease. The use of these models has enabled preclinical chemotherapeutic, chemoprevention, and genetic therapy studies in vivo, the testing of gene delivery systems, and the identification of tumour and metastasis suppressor and inducer genes. This review has discussed the most abundantly used murine models of mammary cancer including: spontaneous tumours, chemically induced tumours, orthotopic and syngeneic tumour transplantation, injected tumours, and genetically engineered mice with a predisposition to neoplasia. Each model has been discussed with regards to its merits and limitations for investigating the genetic and phenotypic alterations involved in the human disease as well as its potential usefulness for the development of new treatment strategies. To date no single mouse model is available with the ability to replicate the entire disease process, however, existing models continue to provide invaluable insights into breast cancer induction and progression that would be impossible to obtain using in vitro models alone.
      datePublished:2005-12-01T00:00:00Z
      dateModified:2005-12-01T00:00:00Z
      pageStart:101
      pageEnd:113
      sameAs:https://doi.org/10.1007/s10549-005-9067-x
      keywords:
         breast cancer
          in vivo models
         metastases
         Oncology
      image:
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:96
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:P.D. Ottewell
            affiliation:
                  name: University of Sheffield
                  address:
                     name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
                     type:PostalAddress
                  type:Organization
                  name: University of Sheffield
                  address:
                     name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:R.E. Coleman
            affiliation:
                  name: University of Sheffield
                  address:
                     name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:I. Holen
            affiliation:
                  name: University of Sheffield
                  address:
                     name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:96
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name: University of Sheffield
      address:
         name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
         type:PostalAddress
      name: University of Sheffield
      address:
         name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
         type:PostalAddress
      name: University of Sheffield
      address:
         name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
         type:PostalAddress
      name: University of Sheffield
      address:
         name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:P.D. Ottewell
      affiliation:
            name: University of Sheffield
            address:
               name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
               type:PostalAddress
            type:Organization
            name: University of Sheffield
            address:
               name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:R.E. Coleman
      affiliation:
            name: University of Sheffield
            address:
               name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
               type:PostalAddress
            type:Organization
      name:I. Holen
      affiliation:
            name: University of Sheffield
            address:
               name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
      name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
      name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
      name:Academic Unit of Clinical Oncology, School of Medicine and Biomedical Sciences, University of Sheffield, Sheffield, UK
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(326)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.38s.

LINK . SPRINGER . COM {}